MedTrace Logo

Intestinal Microbiota Composition After Antibiotic Treatment in Early Life

NCT02536560 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2015-09-01

No results posted yet for this study

Summary

In this prospective observational cohort study the potential clinical consequences of antibiotic use in early life and perturbations in the gastrointestinal microbiota composition due to that antibiotic use are studied. It is hypothesized that altered microbiota may be an important underlying mechanism for impediments in the developing immune system.

Differentiation will be made between a group of neonates who received antibiotics in the first week of life, and control infants who were not exposed to antibiotics in the neonatal period.

Conditions

Sponsors & Collaborators

  • Danone Global Research & Innovation Center

    collaborator INDUSTRY

  • Amsterdam UMC, location VUmc

    collaborator OTHER

  • Agentschap NL

    lead OTHER_GOV

Principal Investigators

  • Arine M Vlieger, MD, PhD · St Antonius Hospital Nieuwegein, the Netherlands

Eligibility

Min Age
1 Hour
Max Age
7 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2016-04-30
Completion
2016-10-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02536560 on ClinicalTrials.gov